Howard Marks
Oaktree Capital Management
Howard Marks CERo Therapeutics Holdings Inc stake
total: 853
Oaktree Capital Management CEROW trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2022 Q1
According to 2026 Q2 report, Howard Marks doesn't hold any CERo Therapeutics Holdings Inc (CEROW) shares. Oaktree Capital Management first purchased CEROW in 2021 Q4, initially acquiring 100,000 shares. Since the initial investment in CERo Therapeutics Holdings Inc (CEROW), Oaktree Capital Management has made 1 more transaction.
When did Howard Marks sell CERo Therapeutics Holdings Inc (CEROW)?
Howard Marks sold off the entire CERo Therapeutics Holdings Inc (CEROW) position in 2022 Q1.
Howard Marks's historical trades in CERo Therapeutics Holdings Inc
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q1
|
0.00%
|
0
|
|
|
-100% (-100,000)
|
|
|
2021 Q4
|
0.00%
|
100,000
|
|
|
new
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.